Craig Asher is an accomplished investment professional with extensive experience in the biotechnology sector. Currently serving as Managing Director at OMX Ventures since April 2020, Craig focuses on investing in bio tools and therapeutics startups. Additionally, Craig holds the position of Managing Partner at Trancos Ventures and has been involved with several companies as a board member or observer, including VedaBio, Constructive Bio, and Glyphic Biotechnologies. Craig's background also includes a principal role at Vital Venture Capital LLC, where efforts are being made to wind down the firm while continuing to support existing portfolio investments. Craig's educational qualifications include an MBA in Marketing, Finance, and Operations from Northwestern University's Kellogg School of Management, a Master's in Industrial Engineering from Northwestern University, and an AB in Political Science from Stanford University.